SOPHiA GENETICS SA (SOPH) Misses Q3 EPS by 7c ; Offers Guidance

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $18.3 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2025 revenue of $75-77 million, versus the consensus of $74.52 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• Sandisk (SNDK) call put ratio 1.1 calls to 1 put on active option volume of 300K contracts as share price up 7.5%
• Enovix Corporation (ENVX) PT Lowered to $10 at Cantor Fitzgerald